Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06777108 · ClinicalTrials.gov registry record · NA
Pharmacokinetics of Berkeley Life Oral Nitrate Supplementation
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
NCT06777108: Completed NA study, sponsored by University of Virginia.
NCT06777108 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06777108, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
Study Summary
The purpose of the study is to examine the way that a nitric oxide supplement moves through the body. Specifically, the relationship between saliva and blood concentration of the supplement and the elapsed time since taking the supplement. Participants will : * Come to UVA to participate in testing procedures. * Take a nitric oxide supplement up to twice. * Complete a pregnancy test if the participant is a pre-menopausal female. * Produce saliva into a tube to collect a sample. * Undergo several blood draws (less than 6 tablespoons). * Wear a 24-hour non-invasive device that monitors the participant's blood pressure.
Primary Outcome
Change in plasma nitrite over a 24-hour period. Measured at the following timepoints: baseline (before single-dose supplementation), 2 hours, 4 hours, 8 hours, and 24 hours following single-dose supplementation.
Interventions
- DIETARY_SUPPLEMENT Inorganic Nitrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2024-02-07 |
| Est. Completion | 2024-04-06 |
| Phase | NA |
What the finished NCT06777108 record still lists
NCT06777108 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Inorganic Nitrate is the first listed.
NCT06777108 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06777108 about?
NCT06777108 is a clinical study titled "Pharmacokinetics of Berkeley Life Oral Nitrate Supplementation". The purpose of the study is to examine the way that a nitric oxide supplement moves through the body. Specifically, the relationship between saliva and blood concentration of the supplement and the elapsed time since taking the supplement. Participants will : * Come to UVA to participate in testin...
What is the current status of trial NCT06777108?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2024-02-07. Estimated completion is 2024-04-06.
What interventions are being tested in trial NCT06777108?
The interventions under investigation include: Inorganic Nitrate (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06777108?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06777108's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI